NENCETTI, SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.525
EU - Europa 4.197
AS - Asia 1.276
AF - Africa 100
SA - Sud America 14
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.128
Nazione #
US - Stati Uniti d'America 7.015
CA - Canada 2.508
IT - Italia 1.426
SE - Svezia 781
CN - Cina 594
DE - Germania 459
BG - Bulgaria 354
PL - Polonia 338
GB - Regno Unito 237
SG - Singapore 212
TR - Turchia 191
UA - Ucraina 144
FR - Francia 138
FI - Finlandia 135
VN - Vietnam 114
IN - India 62
SN - Senegal 46
CH - Svizzera 45
HK - Hong Kong 33
RU - Federazione Russa 31
BE - Belgio 28
CI - Costa d'Avorio 28
AT - Austria 21
JP - Giappone 20
KR - Corea 16
NG - Nigeria 16
GR - Grecia 11
BR - Brasile 10
AU - Australia 8
ES - Italia 8
IR - Iran 7
NL - Olanda 7
TW - Taiwan 7
CZ - Repubblica Ceca 5
HR - Croazia 5
ID - Indonesia 5
NZ - Nuova Zelanda 5
RO - Romania 5
IE - Irlanda 4
IL - Israele 4
MA - Marocco 4
BY - Bielorussia 3
HU - Ungheria 3
BN - Brunei Darussalam 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
ZA - Sudafrica 2
A1 - Anonimo 1
BD - Bangladesh 1
CO - Colombia 1
JO - Giordania 1
KH - Cambogia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 15.128
Città #
Montreal 2.297
Woodbridge 1.045
Ann Arbor 827
Chandler 656
Houston 634
Fairfield 600
Ashburn 370
Sofia 353
Serra 348
Milan 276
Seattle 265
New York 237
Beijing 233
Wilmington 221
Cambridge 198
Ottawa 193
Izmir 183
Jacksonville 183
Princeton 178
Lawrence 136
Medford 130
Des Moines 112
Nanjing 109
Florence 96
Dearborn 80
Singapore 75
London 69
Dong Ket 68
Redwood City 51
Frankfurt am Main 49
Bremen 47
Dakar 46
Bern 45
Marseille 38
Rome 38
Ogden 37
Pisa 37
Lancaster 36
San Diego 34
Hong Kong 32
Nanchang 31
Jüchen 30
Abidjan 28
Brussels 27
Boulder 26
Bures-sur-Yvette 26
Kunming 25
Pessac 23
Pune 22
Vienna 21
Jiaxing 20
Livorno 20
Los Angeles 20
Shenyang 20
Hefei 18
Nürnberg 18
Norwalk 17
Trieste 17
Auburn Hills 16
Boardman 16
Changsha 16
Hebei 16
Lagos 16
Grafing 15
Tianjin 13
Alessandria 12
Hangzhou 12
Paris 12
Warsaw 12
Phoenix 11
San Francisco 11
Chicago 10
Düsseldorf 10
Bergamo 9
Cerveteri 9
Guangzhou 9
Dallas 8
Padova 8
Tokyo 8
Washington 8
Dundee 7
Toronto 7
Gif-sur-yvette 6
Haikou 6
Lucca 6
Orange 6
Tagliacozzo 6
Falls Church 5
Genova 5
Helsinki 5
Jinan 5
San Giuliano 5
Zagreb 5
Buffalo 4
Cagliari 4
Calci 4
Cascina 4
Changchun 4
Chengdu 4
Edinburgh 4
Totale 11.430
Nome #
Synthesis and a- and ß-adrenergic activity of spiromorpholines structurally related to sympathomimetic catecholamines 2.699
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs 207
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 163
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 149
Copper mediated amyloid-β binding to Transthyretin 149
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter 147
SYNTHESIS AND EVALUATION OF THE PHARMACOLOGICAL ACTIVITY OF RIGID ANALOGUES OF SYMPATHOMIMETIC DERIVED FROM BICYCLO[2.2.1]HEPTANE 143
Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: synthesis and antiinflammatory properties 141
3-(METHYLENEAMINOXY)METHYLPIPERIDINE DERIVATIVES AS UPTAKE INHIBITORS OF BIOGENIC-AMINES IN THE BRAIN SYNAPTOSOMAL FRACTION 140
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 139
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 138
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 135
Inhibition of [125] ET-1 binding to ETA receptors by salicilic acid dimers 134
7-Nitrobenzofurazan (NBD)-Derivatives Of 5'-N-Ethylcarboxamidoadenosine (NECA) As New Fluorescent Probes For Human A3 Adenosine Receptors 133
3-(Methyleneaminoxy)methylpiperidine derivatives as uptake inhibitors of biogenic amines in the brain synaptosomal fraction 129
Synthesis and 5-HT2A, 5-HT1Aand a1-Binding Affinities of 2-[2- Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-Hydroxy-3-(2- pyridin-2-yl-ethyl)amino]- and 2-[2-Hydroxy-3-(4-N-methylpiperazin- 1-yl)-amino]propoxybenzaldehyde-O-(substituted) Benzyl Oximes 128
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 128
TTR fibril formation inhibitors: is there a SAR? 125
Synthetic analogs of xanthohumol for use in the prevention and​/or treatment of tumors 125
Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds 124
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 123
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 122
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 121
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 121
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 120
4-ARYLPIPERIDINE DERIVATIVES AND USE THEREOF FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CNS DISEASE 120
Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models 120
Sintesi e proprietà farmacologiche di analoghi semirigidi morfolinici e piperidinici di catecolamine simpatomimetiche. Modelli sterici per l'attivazione diretta dei recettori a- e ß-adrenergici. 119
Synthesis and β-adrenergic properties of tetrahydronaphthalene analogs of dichloroisoproterenol 119
CONFORMATIONALLY RESTRAINED ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES - SYNTHESIS AND ADRENERGIC ACTIVITY OF TETRAHYDROBENZOCYCLOHEPTENE DERIVATIVES 118
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 118
SYNTHESIS AND EVALUATION OF THE PHARMACOLOGICAL ACTIVITY OF RIGID ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES DERIVED FROM BICYCLO[2.2.1]HEPTANE 117
Comparison of helical scan and standard rotation methods in single-crystal X-ray data collection strategies 117
Role of the benzylic hydroxyl group of adrenergic catecholamines in eliciting a-adrenergic activity. Synthesis and a1- and a2-adrenergic activity of 3-phenyl-3-piperidinols and of their desoxy analogs 116
Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-a Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models 116
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies 116
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 115
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors 114
Age-related macular degeneration: Current knowledge of zinc metalloproteinases involvement 114
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 113
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 111
MOLECULAR DESIGN, SYNTHESIS, AND ANTIINFLAMMATORY ACTIVITY OF A SERIES OF BETA-AMINOXYPROPIONIC ACIDS 110
Synthesis and affinity for serotonin and dopamine transporters of some benzophenone oxime ether derivatives 110
Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines 110
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 109
A new crystal form of human transthyretin obtained with a curcumin derived ligand 107
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 106
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 106
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 106
Synthesis and antimicrobial properties of new cepham and penam derivatives with the carboxylic group in the "wrong" ß-configuration 105
Powerful twin carboxylic inhibitors for MMP homodimerization 105
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 105
X-ray crystal structure and activity of fluorenyl-based compounds as transthyretin fibrillogenesis inhibitors 104
1-(1-pirril)-3- ammino-2-propanoli N-sostituiti: sintesi e proprietà ß-adrenergiche 103
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates 103
null 103
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP 102
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 101
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 101
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 97
Sintesi e proprietà beta-adrenergiche di [(benzilideneammino)ossi] propanolammine orto-ossipropanolammine sostituite chirali, 97
A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 97
Conformationally restrained analogs of sympathomimetic catecholamine. Synthesis and adrenergic activity of tetrahydrobenzocycloheptene derivatives 96
Tafamidis (Vyndaqel): A Light for FAP Patients 94
WILSON & GISVOLD CHIMICA FARMACEUTICA (Capitolo 15) 94
Transthyretin complexes with curcumin and bromo-estradiol: Evaluation of solubilizing multicomponent mixtures 92
Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles 92
Exploring the binding of quercetin-3-O-metabolites with transthyretin 91
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators 91
Synthesis and aldose reductase inhibitory activity of new N-(benzyloxy) glycine derivatives 90
CONFORMATIONAL EFFECTS ON THE ACTIVITY OF DRUGS .13. A REVISION OF PREVIOUSLY PROPOSED MODELS FOR THE ACTIVATION OF ALPHA-ADRENERGIC AND BETA-ADRENERGIC RECEPTORS 88
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 88
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 88
Sintesi e attività recettoriale adrenergica di analoghi tetraidronaftalenici di catecolamine simpatomimetiche 87
Uncommon formation of spiro orthoesters in the bromomethoxylation reaction of a 4-[(aroyloxy)methyl]-3-cephem derivative 87
Higher Crystallization Success Obtained for TTR-ligand Complexes Using a New Approach 87
Allosteric inhibition of ET-1 binding to ETA receptors by aldoxime derivatives 85
A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 83
Conformational effects on the activity of drugs. Synthesis and a and ß-adrenergic receptor activity of new terahydronaphthalene analogs of sympathomimetic catecholamines 82
Synthesis and aldose reductase inhibitory activity of N-(aroyl)- and N-(arylsulfonyl)-N-(benzyloxy)aminoacetic acids. 82
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR) 82
Effetti conformazionali sull'attività dei farmaci. Sintesi e proprietà farmacologiche di cis-2-aril-3-metilmorfoline 81
D2 dopamine receptor agonists as allosteric modulators of A2A adenosine receptor signalling 81
Synthesis and evaluation of beta3-adrenergic affinity of new oximethereal derivative 79
Spirotetrahydronaphthalene analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro(naphtalen-1(2H)-3'-piperidines) 79
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit a- and ß-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms 78
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of a- and ß-adrenergic receptors 77
Conformational effects on the activity of drugs. 11. Stereostructural models for the direct activation of the a- and ß-adrenergic receptor 77
New chromane, thiocromane and tetrahydronaphtalene oxime ether derivatives combining SERT and a2-adrenoceptor affinity 77
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 76
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 76
Effetti conformazionali sull'attività dei farmaci. Sintesi e valutazione dell'attività farmacologica di analoghi rigidi di catecolamine simpatomimetiche derivati dal norbornano 75
Sintesi ed attività adrenergica di analoghi ciclici dell’1-(2,5-dimetossifenil)-2-amminoetanolo 73
Chiral 2-(3'-(5'-p-chlorophenyl)isoxazolidinyl)ethanolamines as conformationally restrained analogs of methyloxyiminomethyl (MOIM) beta-adrenergic antagonists: Synthesis, configuration and beta-adrenergic properties 73
Synthesis and aldose reductase inhibitory activity of some N-(aroyl)-N-(arylalkyloxy)-glycines and -beta-alanines 73
NMR STUDIES OF A NEW POTENT MMP-12 INHIBITOR: INSIGHT INTO KEY BINDING INTERACTIONS 71
Oximethereal piperidinic derivatives: synthesis and affinity for serotonin and dopamine transporters 71
Design of Selective Collagenase 3 (MMP-13) Inhibitors as Potential Therapeutic Agents in Rheumatoid Arthritis 71
null 71
Synthesis of heteroaromatic analogs of (2-aryl-1-cyclopentenyl-1-alkylidene)(arylmethyloxy)amine COX-2 inhibitors: effects on the inhibitory activity of the replacement of the cyclopentene central core with pyrazole, thiophene or isoxazole ring 70
Totale 13.141
Categoria #
all - tutte 35.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.977 234 161 180 115 171 230 223 124 163 146 170 60
2020/20211.112 79 50 46 41 96 101 108 142 129 97 63 160
2021/20221.831 45 193 39 98 315 219 66 94 71 49 115 527
2022/20232.223 290 299 167 217 224 284 26 143 364 12 147 50
2023/20244.123 202 134 157 81 236 282 85 53 27 2.639 83 144
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 15.499